Home » Newsletters » BioWorld Science

BioWorld Science

March 22, 2000

View Archived Issues

Chrysalin accelerates fracture healing in preclinical animal studies

Dermagraft epicardial patch induces angiogenesis in preclinical studies

Alliance makes progress in phase II/III LiquiVent trial

Oral Hectorol clinical progress updated

StressGen initiates phase II study with HspE7 in high-grade cervical dysplasia

Pharmadigm reports phase II results for DHEAS in burn patients

Phase I study of AltaRex's BrevaRex MAb completed

Dura enters definitive merger agreement to acquire Spiros

Norditropin SimpleXx approved in Japan

Drug notification issued for Pulmozyme due to packaging defect

Val-HeFT study to investigate benefits of Diovan in heart failure

New ADIR compounds particularly useful for solid tumors

AstraZeneca synthesizes amide derivatives as cytokine production inhibitors

SB adds another anticonvulsant series to its pipeline

Spanish lab describes early research results in the area of COX-2 inhibitors

Lilly presents another series of indole sPLA2 inhibitors

Novel lactams prepared at DuPont inhibit Abeta-peptide production

Known antiallergic agent from Kyorin now claimed for use in MS

Gallic acid induces oxidation-dependent apoptosis in human lung cancer cells

Ferriprox launched in Europe

Antiproliferative and apoptosis-inducing effects of NS-398

Coreg trial stopped early due to positive results

Shionogi's TxA2 receptor antagonist inactive in model of silica-induced lung fibrosis

Effects of TAK-603 on cytokine production reported at Japanese congress

Warner-Lambert discontinues sale of Rezulin

Magainin A: rabbit studies suggest its promise as a vaginal contraceptive

Early clinical results presented for SB-242235 at scientific meeting

Comparative studies with Hoe-901 and other insulins reported at ASCPT

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026